November 20, 2025 a 04:38 pm
CVS: Analysts Ratings - CVS Health Corporation
The CVS Health Corporation stock has maintained consistent interest among analysts with predominantly favorable ratings over the past months. With its wide-reaching health services, including pharmacy benefit management and retail operations, CVS continues to attract a positive outlook. The absence of any strong sell or sell ratings reflects an underlying confidence in its market position, underscored by its diverse income streams and robust presence across healthcare segments.
Historical Stock Grades
The latest data indicates a promising stance towards CVS, reflected through the analysts' ratings. Notably, there is a significant incline towards positive recommendations, complementing a stable market presence.
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 6 | |
| Buy | 17 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Recent months reveal dynamic shifts in the sentiment with analysts tilting more towards positive ratings. Here are the observations:
- A slight decrease in Strong Buy ratings during October shows potential caution.
- Consistent Hold ratings may indicate a wait-and-see approach by some analysts.
- The Buy recommendations remain robust, showcasing confidence in the company's fundamentals.
- Total rating counts have varied, illustrating responsive shifts to market movements.
Percentage Trends
Taking a closer look at the percentage trends over time, a few key changes are noticeable:
- Strong Buy recommendations have dropped from earlier highs, indicative of moderated enthusiasm.
- Buy ratings have stabilized, consistently comprising around 60% of total ratings.
- Hold ratings have seen fluctuations, currently lower than six months ago, pointing to a more decisive market sentiment.
- No Sell or Strong Sell indications, signifying general confidence.
- The balance in ratings reflects a cautious optimism influenced by enduring market conditions and company stability.
Latest Analyst Recommendations
Analysts largely maintain their current recommendations, highlighting confidence in the stock's potential. Here are the latest updates:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-13 | Overweight | Overweight | Wells Fargo |
| 2025-11-03 | Buy | Buy | TD Cowen |
| 2025-10-30 | Overweight | Overweight | Cantor Fitzgerald |
| 2025-10-30 | Outperform | Outperform | Evercore ISI Group |
| 2025-10-30 | Outperform | Outperform | RBC Capital |
Analyst Recommendations with Change of Opinion
Several rating upgrades indicate shifts in analyst perspectives. These changes may suggest an evolving positive view of the stock's future prospects:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-18 | Buy | Neutral | UBS |
| 2025-08-14 | Outperform | Neutral | Baird |
| 2025-02-13 | Outperform | Market Perform | Leerink Partners |
| 2024-12-03 | Buy | Hold | Deutsche Bank |
| 2024-11-18 | Overweight | Equal Weight | Wells Fargo |
Interpretation
The data reflects a robust market confidence in CVS with stable support from both Buy and Strong Buy recommendations. The consistent absence of negative ratings across various months underscores analysts' belief in the resilience and growth potential of CVS's diverse business model. The occasional downgrades to Hold can point to sector-specific challenges or broader economic caution. Nevertheless, the overall sentiment remains decisively positive, indicating trust in its strategic initiatives and expansion plans.
Conclusion
CVS Health Corporation enjoys continued strength in analyst confidence, signified by sustained Buy recommendations and stable Strong Buy attitudes. The company's consistent performance across its diverse segments draws positive sentiment from the market. The lack of sell ratings further emphasizes its stability. Over the past quarters, CVS has shown adaptability to market conditions while leveraging its unique business model, projecting opportunities for growth. Analysts' reviews suggest cautious optimism, balanced by external economic pressures. For stakeholders, this underscores a favorable risk profile with prospects for sustained returns.